By exploring AIM1L in the National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/), it was found that it was highly expressed in normal human tissues such as the esophagus and skin.[5] A mass spectrometry analysis showed that AIM1L mRNA was highly expressed in some cancer cell lines, including breast cancer, colon cancer, ovarian cancer, and in noncancerous tissues only in the placenta. Here, CRYBG2 is linked to breast cancer.